SARS-CoV-2 epitopes inform future vaccination strategies

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Current COVID-19 vaccines use the spike protein, but SARS-CoV-2 variants can evade immune responses.
• Mutations in spike proteins of variants of concern (VOCs) lead to reinfection and reduced vaccine effectiveness.

Purpose of the Study:

• To review studies on SARS-CoV-2 antibody and T-cell epitopes for next-generation vaccine development.
• To explore the potential of T-cell epitopes for broader coronavirus protection and overcoming immune escape.

Main Methods:

• Literature review of major studies on SARS-CoV-2 antibody and T-cell epitopes.
• Analysis of epitope targets for neutralizing antibodies and T-cell responses.

Main Results:

• SARS-CoV-2 variants exhibit spike protein mutations that facilitate immune escape.
• T-cell epitopes, targeting antigens beyond spike, offer a promising strategy against VOCs.
• Identifying broadly neutralizing antibody and T-cell epitopes is key for future vaccine design.

Conclusions:

• Future vaccines may target multiple SARS-CoV-2 epitopes for enhanced efficacy.
• Pan-coronavirus vaccines protecting against various coronaviruses are a potential future development.
• Augmenting T-cell responses presents a viable strategy to ensure protection against immune-evasive VOCs.